Walgreens Boots Alliance (NASDAQ:WBA) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a research note issued to investors on Thursday. The firm issued a hold rating on the pharmacy operator’s stock.

A number of other equities analysts also recently commented on WBA. Bank of America raised their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada raised their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Finally, Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Trading Down 3.4 %

NASDAQ WBA opened at $10.68 on Thursday. The company has a market cap of $9.23 billion, a P/E ratio of -1.04, a P/E/G ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance has a 12 month low of $8.08 and a 12 month high of $19.48. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company has a 50-day moving average of $10.75 and a 200-day moving average of $9.98.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.66 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance will post 1.6 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in WBA. First Financial Corp IN boosted its holdings in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth approximately $26,000. Riverview Trust Co grew its holdings in Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after purchasing an additional 1,590 shares during the last quarter. Colonial Trust Co SC lifted its stake in shares of Walgreens Boots Alliance by 79.5% in the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock worth $27,000 after buying an additional 1,297 shares during the last quarter. Finally, Venturi Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter worth about $28,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.